NEW YORK (GenomeWeb) – Venture development company TechAccel said this week that it has invested in agricultural biotechnology company Epicrop Technologies. Epicrop is developing an epigenetic technology to improve crop yields. The investment is part of Epicrop's extended Series A round, which raised a total of $3.2 million. Additional investments were made by North Forty Ventures, Nelnet, Speedway Properties, and Allen & Company. TechAccel and Epicrop are also planning to create a joint venture to pursue new target crops using Epicrop's technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.